We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cord Blood America Acquires CorCell

By HospiMedica staff writers
Posted on 25 Oct 2006
Cord Blood America, Inc. More...
(Los Angeles, CA, USA) has acquired the umbilical cord-blood stem-cell preservation company CorCell, Inc. (Philadelphia, PA, USA).

Cord Blood America purchased the operating entity and assets of CorCell on October 13, 2006. In addition, the agreement gives Cord Blood America exclusive rights to make an additional purchase of the current approximately 12,000 customers of CorCell by March 31, 2007. Financial details were not disclosed for either transaction.

CorCell, established in 1995, collects umbilical cord blood stem cells from hospitals in all 50 states as well as internationally. The company has grown its primary business through strategic partnerships with health insurers throughout the United States. CorCell will retain its operating name.

"We have consistently said that accretive acquisitions are the most sensible way to grow in this soon-to-be U.S.$1 billion market,” said Matthew Schissler, CEO of Cord Blood America. "Cord Blood America is very pleased for its shareholders to have acquired this strong, successful private company. This acquisition is very important for our future.”

Cord Blood America is the parent company of CorCell, which facilitates cord-blood stem-cell preservation for expectant parents and their children. Its mission is to be the most respected stem-cell-preservation company in the industry. Collected through a safe and noninvasive process, cord blood stem cells offer a potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, and blood and immune disorders.



Related Links:
Cord Blood America
CorCell

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Medical-Grade Display
HL2316SHTB
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Conceptual schematic of MEND in combination with eCPCs for laryngotracheal reconstruction (Gehret, P., Ali Akbari Ghavimi, S., Dumas, A.A. et al.Nature Communications (2026). DOI: 10.1038/s41467-026-73680-2)

Personalized Cartilage Graft Offers New Option for Infants with Severe Airway Narrowing

Severe subglottic stenosis is a narrowing of the airway below the vocal cords and above the trachea. The condition can leave infants dependent on tracheostomy while awaiting reconstructive surgery to enable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.